PharVision Advisers’s Coursera COUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-33,353
Closed -$245K 223
2025
Q4
$245K Buy
33,353
+10,135
+44% +$88.3K 0.12% 403
2025
Q3
$272K Buy
+23,218
New +$252K 0.15% 287
2025
Q2
Sell
-12,983
Closed -$86.5K 297
2025
Q1
$86.5K Buy
+12,983
New +$103K 0.12% 254

Other funds holding COUR

PharVision Advisers's COUR Position: Q1 2026 in Review

PharVision Advisers sold out of Coursera (COUR) in Q1 2026, closing a stake of 33,353 shares — an estimated $245K sold.

PharVision Advisers first reported a position in COUR in Q1 2025 and held it in 3 quarters. The position peaked at $272K in Q3 2025. 236 funds tracked by Wall St. Rank hold COUR as of Q1 2026.

  • PharVision Advisers reported no remaining Coursera position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 33,353 Coursera shares in Q1 2026, an estimated $245K.
  • PharVision Advisers first reported a position in Coursera in Q1 2025 and held it in 3 quarters.
  • PharVision Advisers's Coursera position peaked at $272K in Q3 2025.
  • 236 funds tracked by Wall St. Rank held Coursera as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.